aerobic exercise on NF-B activity is due to the differential activation of these upstream signaling cascades is usually yet to be determined

aerobic exercise on NF-B activity is due to the differential activation of these upstream signaling cascades is usually yet to be determined. The stimulation of NF-B by exercise seems counterintuitive, since the NF-B pathway has been associated with insulin resistance, whereas physical activity typically improves insulin sensitivity. baseline, NF-B activity was Nafamostat elevated 2.1- and 2.7-fold in obese nondiabetic and T2DM Nafamostat subjects, respectively. NF-B activity was Nafamostat increased significantly at 210 min following exercise in slim (1.9-fold) and obese (2.6-fold) subjects, but NF-B activity did not change in T2DM. Exercise increased MCP-1 mRNA levels significantly in the three groups, whereas IL-6 gene expression increased significantly only in slim and obese subjects. MCP-1 and IL-6 gene expression peaked at the 40-min exercise time point. We conclude that insulin-resistant subjects have increased basal NF-B activity in muscle mass. Acute exercise stimulates NF-B in muscle mass from nondiabetic subjects. In T2DM subjects, exercise had no effect on NF-B activity, which could be explained by the already elevated NF-B activity at baseline. Exercise-induced MCP-1 and IL-6 gene expression precedes raises in NF-B activity, suggesting that other factors promote gene expression of these cytokines during exercise. Keywords:nuclear factor-B, skeletal muscle mass, monocyte chemotactic protein-1, interleukin-6 type 2 diabetes mellitus(T2DM) and obesity are insulin-resistant disorders characterized by chronic inflammation (17,20). Nuclear factor-B (NF-B) is usually a family of transcription factors that control the production of proinflammatory proteins. Data accumulated in recent years suggest that increased NF-B signaling may be involved in the pathogenesis of insulin resistance (3,4,32,50,56). Elevated activity of this transcription factor has also been linked to muscle loss (11) and weakness (29), features seen generally in diabetic subjects (40). In the basal state, NF-B is usually localized in the cytoplasm associated with the inhibitory protein inhibitor B (IB). Stimuli such as cytokines (19), reactive oxygen species (19), hyperglycemia (19), and free fatty acids (FFAs) (30) activate IB kinase (IKK), which is a complex of kinases that phosphorylate IB. IB phosphorylation by IKK leads to IB ubiquitination and proteasomal degradation. The IBs are users of a gene family that includes IB, -, -, and – and Bcl-3 (24). The IB and – isoforms have been the most widely analyzed, and both can sequester and inhibit NF-B. Following release from IB, NF-B translocates to the nucleus, where it regulates gene transcription of inflammatory proteins such as interleukin (IL)-6, monocyte chemotactic protein-1 (MCP-1), IL-1, and interferon- (19,38). NF-B proteins consist of five members, including p65, p50, p52, RelB, and c-Rel. Dimerization of two NF-B family members is necessary to exert its DNA-binding activity. The predominant activating NF-B dimer in skeletal muscle mass is usually p50/p65 (31). Increased IKK/NF-B signaling is usually thought to inhibit insulin signaling through insulin receptor substrate-1 serine phosphorylation by IKK (23) and NF-B-mediated expression of inflammatory proteins (3). Despite the evidence from cell culture and animal studies indicating that NF-B may be involved in insulin resistance (34,56), it is not known whether insulin-resistant subjects have abnormal NF-B activity in muscle mass. Considering the role that NF-B plays on myocellular differentiation (5) and muscle mass function (31), it is important to know whether exercise affects NF-B activity and to understand the physiological significance of such a change. Muscle mass contraction promotes the generation of reactive oxygen species (43) and raises intracellular calcium levels (8). Because reactive oxygen species (19) and calcium-regulated signaling cascades (27) activate NF-B, one might expect exercise to increase the activity of this transcription factor. Nonetheless, there have been contradictory findings with respect to the effect of exercise on NF-B. In rodents, acute treadmill running raises NF-B activity in muscle mass (26,32). In contrast, a study in healthy human subjects reported that resistance exercise reduced NF-B activity (18). We found that aerobic (cycle) training increased the content of the NF-B inhibitory protein IB Nafamostat in human muscle, which would be expected to decrease NF-B activity (51). Schenk and Horowitz (48) also reported that a single bout of aerobic exercise was sufficient to increase the content of this inhibitory protein in human muscle mass. Although these data suggest that exercise inhibits NF-B signaling in humans, the effect of acute aerobic exercise on NF-B activity in normal glucose-tolerant and insulin-resistant subjects is not known. The goals of this study were to examine whether insulin-resistant subjects have increased NF-B activity and to determine the effect of acute aerobic Rabbit polyclonal to Albumin exercise on NF-B activity/signaling in human muscle. Nafamostat == METHODS == == == == Subjects. == We analyzed 13 obese [body mass index (BMI) = 32.8 1.1 kg/m2] type 2 diabetic, 10 obese (BMI = 32.6 1.5 kg/m2) nondiabetic, and 11 nonobese (BMI = 25.1 0.7 kg/m2) nondiabetic subjects. Even though mean BMI of the nonobese nondiabetic group is higher than the World Health Organization’s definition of normal weight (BMI <25 kg/m2), for the purpose of this study this group will be referred to as slim. All subjects were sedentary. Each subject underwent a medical history, physical examination, testing laboratory assessments, and a 75-g oral glucose tolerance test (OGTT). Six T2DM subjects took sulfonylureas, which were stopped 2 days before the OGTT, the insulin clamp, and the acute.